ArticleRespirology case reports2026
Endovascular Stent-Graft Exclusion for the Treatment of Haemoptysis Caused by Central Pulmonary Artery Pseudoaneurysm: A Case Report.
Article in Respirology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endovascular Stent-Graft Exclusion for the Treatment of Haemoptysis Caused by Central Pulmonary Artery Pseudoaneurysm: A Case Report.Respirology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary artery pseudoaneurysm (PAP) is a rare lethal disease; central tuberculous PAP carries a mortality rate of 50%-90% and often responds poorly to conventional embolization. We report a 59-year-old tuberculous woman with recurrent haemoptysis secondary to left main PAP. Covered stent-graft exclusion was conducted after failed conservative treatment and bronchial artery embolization, with complete haemostasis and no recurrence at 1-year follow-up. Most existing literature adopts vessel-occlusive embolization for PAP, which may cause pulmonary infarction. Moreover, stent-graft implantation for main pulmonary artery lesions is seldom reported due to dimensional mismatch between large native main pulmonary arteries and commercially available covered stent-grafts (maximum diameter 12 mm). Our case uniquely confirms that precise preoperative vascular measurement allows successful deployment of a 12 mm stent-graft within the 11 mm proximal arterial segment, providing rare long-term follow-up evidence of durable haemostasis and preserved pulmonary patency via this vessel-preserving intervention strategy for central PAP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.